Summit X’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Summit X's AMGN Position: Q3 2025 in Review
Summit X sold out of Amgen (AMGN) in Q3 2025, closing a stake of 824 shares — an estimated $230K sold.
Summit X first reported a position in AMGN in Q2 2024 and held it in 4 quarters. The position peaked at $455K in Q4 2024. 2,833 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.
- Summit X reported no remaining Amgen position as of Q3 2025 after selling out during the quarter.
- Summit X sold 824 Amgen shares in Q3 2025, an estimated $230K.
- Summit X first reported a position in Amgen in Q2 2024 and held it in 4 quarters.
- Summit X's Amgen position peaked at $455K in Q4 2024.
- 2,833 funds tracked by Wall St. Rank held Amgen as of Q3 2025.
Based on Summit X's 13F filing for Q3 2025.